3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma, B-Cell
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Teratoma
1
Seminoma
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Osteosarcoma
1
Nonseminomatous germ cell tumor
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Histiocytosis, Langerhans-Cell
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
8
Specimen Handling
7
X-Rays
6
Phantoms, Imaging
6
Vincristine
5
Nuclear Medicine Department, Hospital
5
Cisplatin
5
Temozolomide
4
Radiotherapy
4
Biopsy
4
Lomustine
3
Etoposide
3
Carboplatin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiation
2
Platinum
2
Irinotecan
2
1,2-diaminocyclohexaneplatinum II citrate
2
tazemetostat
1
omburtamab I-131
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Medulloblastoma
×
etoposide phosphate
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled